Ancient herbs take on chemo nerve pain: early trial begins
NCT ID NCT07626528
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a traditional Chinese medicine formula, Wenyang Tongbi Granules, can reduce nerve pain and numbness caused by chemotherapy. 144 adults with breast or colorectal cancer who develop hand-foot tingling or pain during chemo will receive either the herbal granules or standard mecobalamin pills for 42 days. Researchers will measure symptom improvement and changes in blood markers of inflammation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Wenyang Tongbi Granules (traditional Chinese herbal formula)
What this could lead to
If it works, this could offer a new option to ease nerve pain and numbness caused by chemotherapy, improving quality of life for cancer patients.
What could go wrong
This is a very early (Phase 1) trial with only 144 people, so results may not be conclusive. The herbal formula may not work better than existing treatments, and side effects are not yet well understood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Beijing Municipality, 100021, China